Award notice Supplies

Fingolimod (Chlorhydrate)

Notice published in French. The AI analysis summarises it for you in your language.

Public buyer: Cliniques universitaires Saint Luc
Woluwe-Saint-Lambert
Place of performance: 1200 Woluwe-Saint-Lambert, Brussels-Capital
not published: buyer's address
Amount awarded: €211,700 excl. VAT
Planned end of contract: 29 December 2029
likely re-tender around June 2029
Bids received: 2
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Open procedure
Any company may submit a bid.
Publication: 9 January 2026
Notice language: French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Unlimited analyses during the 14-day Pro trial, no card needed.

Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « fingolimod » (chlorhydrate) en gélule.

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33660000

Contract	Winner	Amount
Sugammadex Cliniques universitaires Saint Luc · 5 August 2025	Viatris	€126,000
Sevofluraan AZ Delta vzw · 13 October 2026	Abbvie NV	€1,075,340
Raamovereenkomst voor het leveren van anesthetica Universitair Ziekenhuis Gent · 24 September 2026	PFIZER PFE BELGIUM SPRL Fresenius Kabi NV/SA ORION PHARMA BENELUX Grindeks Kalceks Belgium	€1,696,355
Raamovereenkomst voor het leveren van geneesmiddelen tegen pijn, koorts en osteo-articulaire aandoeningen Universitair Ziekenhuis Gent · 7 September 2026	Arega Pharma Fresenius Kabi NV/SA WillPharma Viatris bv	€1,516,053
Paracetamol IV AZ Delta vzw · 22 July 2026	B.Braun Medical NV	€298,570

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 11265-2026.